Beckman Coulter Buys Flow Cytometry Firm Blue Ocean Biomedical | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Beckman Coulter Life Sciences announced late Thursday it has acquired flow cytometry firm Blue Ocean Biomedical for an undisclosed amount.

According to Beckman Coulter, the deal provides it with low complexity analyzers that integrate automated sample preparation. It added the acquisition will allow it to directly address emerging flow cytometry market trends.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A Karmagenes researcher has lost his position after reportedly admitting to data fabrication, according to Retraction Watch.

Two neuroscientists write in Nature News that solving the "reproducibility crisis" in science may require changing the requirements for publication.

In Nature this week: genomic analysis of prehistoric New Mexicans, a nanopore method for mapping DNA methylation, and more.

A new study finds that adding missing good bacteria to the skin microbiome of atopic dermatitis patients decreases Staphylococcus aureus colonization.